Intermittent Preventative Treatment for Malaria in Infancy
In this study, funded by the Bill and Melinda Gates Foundation, the aim is to determine whether the health of Papua New Guinean infants and young children is improved by reducing malaria during infancy with intermittent preventive treatment with antimalarial drugs. More ...
Enhancing Pregnancy Outcomes
The ability of the health system to reach women and children in rural and remote parts of PNG has declined in recent years. The impact of this is especially evident in the poor health indicators of women. More ...
The Genetic Epidemiology of Severe Malaria (MalGen)
The Malaria Genomic Epidemiology Network (MalGEN) was launched in July 2005, order to fill the gap in our knowledge on human genes associated with susceptibility or resistance to malaria. More ...
Neonatal immunization with pneumococcal conjugate vaccine in PNG
Infants in Papua New Guinea (PNG) are at extremely high risk for invasive pneumococcal (Pnc) disease. Pnc conjugate vaccines (PCV) that are efficacious in American and African infants needed evaluation in this high-risk PNG population under the national accelerated 1-2-3 month schedule and, in order to obtain the earliest possible protection against invasive disease, (neonatal) PCV immunization at birth also needed to be considered. More ...
Better use of public health campaigns for child survival
The unique nature of the most recent Supplementary Immunisation Activity (SIA) in Papua New Guinea, concluding in 2005, means that its evaluation offers an unusual opportunity to address some key questions in health service delivery. More ...